05.09.24 -- Non-Integrating Engineering Strategies To Improve Directed Differentiation

Explore the importance of cleanroom doors in maintaining a sterile environment in industries such as pharmaceutical manufacturing and scientific research labs.

Identifying a trusted supplier that can address the myriad of challenges that accompany development for AAV-based drugs is critical to securing an asset’s ultimate commercial success.

The goal of clarification is to prepare the cell culture feed stream for downstream chromatography and purification. In this poster, we examine data driven strategies for clarifying harvest feed streams.

Read how the incorporation of transfer sets designed to support cell and gene therapies will aid in the implementation of controllable, consistent, and safe cGMP amenable manufacturing procedures.

Consider the challenges presented by the residues left behind by disinfectant solutions in cleanrooms and this collection of effective strategies for their management.

The material and packaging requirements for CGT are undoubtedly unique. Uncover how platforms are being established to support the specific needs of this industry. 

Robin Bliss, Ph.D., and VP of Strategic Consulting guides listeners through the how-to’s of selecting early phase study endpoints, emphasizing clinical relevance and timely measurability.

Advances in oncology, specifically in CAR T cell therapies and TILs, are leading the way in cell and gene therapy. However, costs and complex regulations present challenges.

Bringing allogeneic cell therapy to patient care will require flexible, closed, and automated solutions to support the treatment options and increasing scale of the industry.

Accurately measuring viral titer is a key metric throughout gene therapy development, whether you are in the early stage, scaling production, or running assays for quality control release.

Reduce the time and risks involved in maintaining a traditional bioreactor with this single-use solution for biopharmaceutical manufacturers.